At a Glance
| Gaboxadol | Ibotenic acid | |
|---|---|---|
| Class | Hallucinogens, Depressant | Hallucinogens |
| Common Dose (oral) | 15–30 mg | 30–60 mg |
| Total Duration | 1.5–3.6 hrs | 3–7 hrs |
| Routes | oral | oral |
| Effects | 46 documented | 11 documented |
Gaboxadol, a Hallucinogens, Depressant, and Ibotenic acid, a Hallucinogens, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Gaboxadol is classified as a Hallucinogens, Depressant while Ibotenic acid is a Hallucinogens, meaning they approach altered states through different pharmacological mechanisms. They share 4 documented effects in common, with 42 effects unique to Gaboxadol and 7 unique to Ibotenic acid. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Gaboxadol | Ibotenic acid | |
|---|---|---|
| Class | Hallucinogens, Depressant | Hallucinogens |
| Common Dose (oral) | 15–30 mg | 30–60 mg |
| Total Duration | 1.5–3.6 hrs | 3–7 hrs |
| Routes | oral | oral |
| Effects | 46 documented | 11 documented |
| Level | Gaboxadol | Ibotenic acid |
|---|---|---|
| Threshold | 5 mg | 10 mg |
| Light | 10–15 mg | 10–30 mg |
| Common | 15–30 mg | 30–60 mg |
| Strong | 30–45 mg | 60–100 mg |
| Heavy | 45 mg | 120 mg |
Gaboxadol
Ibotenic acid
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.